SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IVEH - Ives Health Company

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: labs who wrote (11)2/22/2001 3:49:26 PM
From: peter michaelson  Read Replies (1) of 54
 
Hi Labs:

Well, I am beginning to think that this Dr. Slayton-Bedeen, who got his degree from Case WEstern Reserve of Oklahoma does not exist, let alone his American Immulogical Research Foundation.

These guys won't even pay for proofreading.

Peter

"A pioneer in biotechnology, Dr. Slayton-Bedeen's studies began at Northeastern State University, Tahlequah, Oklahoma, where he earned a BS in Chemistry. His education then continued at the University of Oklahoma where he received his Ph.D. from Case Western Reserve University in 1978.

Dr. Slayton-Bedeen's expertise in directing research and development has been utilized by 3rd world Counties i.e. Indonesia, Mexico, Singapore, and Thailand, in developing designs for pharmaceutical intermediate plants and his employment history encompasses such large, well known organizations as NASA and the Federal Aviation Administration, where he was valued for his vast knowledge of pharmacology and toxicology.

After serving at Proctor and Gamble (P&G) as General Manager of Specialty Products Operation, Dr. Slayton-Bedeen requested a grant from his employer to begin work on a cure for HIV. He received $250,000 and began work on the Java Project. When Proctor and Gamble learned that he was reaching greater success with herbal remedies than prescription drugs, they relinquished their interest in the project.

Dr. Slayton-Bedeen continued his research of immunological diseases with his direction of the Java Project in cooperation with the World Health Organization (WHO). Dr. Slayton-Bedeen, now Director of the American Immulogical Research Foundation left Ives Health Company in 1999 to focus solely on his research and continue his mission for a natural treatment approach to preventative medicine. He remains excited by Ives and the potential that his findings have to help millions of people live better lives."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext